You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

73 Results
Guidelines and Advice
Mar 2025
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
Jan 2024
Drug
Other Name(s): Vectibix®
Jan 2025
Drug
Other Name(s): Votrient®
Dec 2024
Drug
Feb 2024
Drug
Other Name(s): Taxol®
Nov 2024
Drug
Other Name(s): Caelyx®
Sep 2025
Drug
Other Name(s): Pomalyst®
Apr 2025
Drug
Other Name(s): Keytruda®
Sep 2025
Regimen
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Sarcoma, 
Kaposi's Sarcoma
Intent: Palliative
Nov 2024

Pages